SCHEMBL491533

SCHEMBL491533

CS(=O)(=O)OCCCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
LMNA P02545 2/20 0.52
ALDH1A1 P00352 2/20 0.52
KDM4E B2RXH2 1/20 0.52
USP2 O75604 1/20 0.52
MMP9 P14780 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
IDO1 P14902 1/20 0.52
CA2 P00918 2/20 0.52
CA1 P00915 1/20 0.52
CA9 Q16790 1/20 0.52
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
FFAR1 O14842 1/20 0.44
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2658522 0.94 KDM4E (0.56) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL3438747 0.93 POLB (0.47) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL8435356 0.93 KDM4E (0.54) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL10390508 0.93 KDM4E (0.54) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL6041286 0.93 KDM4E (0.54) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL23014971 0.93 KDM4E (0.54) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL10390555 0.90 POLB (0.47) POLBLMNAALDH1A1IDO1CA2
SCHEMBL6616820 0.90 KDM4E (0.45) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL6589802 0.88 CA1 (0.66) POLBLMNAALDH1A1KDM4EUSP2
SCHEMBL9574195 0.88 TDP1 (0.50) POLBLMNAALDH1A1KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11623920-B2 Process for preparing pitolisant hydrochloride and solid-state forms thereof NURAY CHEMICALS PRIVATE LIMITED (IN) 2023-04-11 US claimed
CN-107473993-A The preparation method of high-purity m-trifluoromethyl phenylpropanol methanesulfonates 山东新华制药股份有限公司 2017-12-15 CN claimed
CN-105461569-B A kind of alverine citrate novel crystal forms and preparation method thereof 南京海融医药科技股份有限公司 2017-06-06 CN claimed
CN-102584801-B One-pot asymmetric synthesis process of HIV reverse transcriptase inhibitor efavirenz compounds SHANGHAI INST ORGANIC CHEM 2015-02-18 CN claimed
CN-111170923-B DL-tryptophan compound, preparation method and application thereof 上海市伤骨科研究所 2023-07-25 CN disclosed
US-20230219914-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF Nuray Chemicals Private Limiited (IN) 2023-07-13 US disclosed
US-20230219914-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF Nuray Chemicals Private Limiited (IN) 2023-07-13 US disclosed
US-20220402886-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF Nuray Chemicals Private Lmiited (IN) 2022-12-22 US disclosed
US-11242296-B2 Decomposition of organic peroxides and hydrogen peroxide by the iron thiolates and related complexes NUTECH VENTURES (US) 2022-02-08 US disclosed
US-20200181038-A1 DECOMPOSITION OF ORGANIC PEROXIDES AND HYDROGEN PEROXIDE BY THE IRON THIOLATES AND RELATED COMPLEXES BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2020-06-11 US disclosed
CN-111170923-A DL-tryptophan compounds, preparation method and application thereof 上海市伤骨科研究所 2020-05-19 CN disclosed
EP-2019818-B1 PROCESS FOR THE PRODUCTION OF COMPOUNDS VIA HAZARDOUS INTERMEDIATES IN A SERIES OF MICROREACTORS DPX HOLDINGS BV (NL) 2020-03-18 EP disclosed
WO-1999025686-A1 CYCLIC AMINE DERIVATIVES AND THEIR USE AS DRUGS TEIJIN LIMITED (JP) 1999-05-27 WO disclosed
EP-0801063-A1 Thiazolidinedione derivatives having antidiabetic, hypolipidaemic antihypertensive properties, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 1997-10-15 EP disclosed
CN-1117290-A Bicyclic carboxylic acid leukotriene B4 antagonists HOFFMANN LA ROCHE (CH) 1996-02-21 CN disclosed
EP-0682662-A1 BICYCLIC CARBOXYLIC ACID LEUKOTRIENE B 4? ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1995-11-22 EP disclosed
US-5457124-A Antiinflammatory agent HOFFMANN-LA ROCHE INC. (US) 1995-10-10 US disclosed
WO-1995015956-A1 BICYCLIC CARBOXYLIC ACID LEUKOTRIENE B4 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1995-06-15 WO disclosed
US-4582854-A BRONCHODILATOR, ANTIINFLAMMATORY AGENT, ANALGESIC E. R. SQUIBB & SONS, INC. (US) 1986-04-15 US disclosed
US-4221816-A Method for the control of phytopathogenic fungi using p-(alkoxyalkyl)urea compounds AMERICAN CYANAMID COMPANY (US) 1980-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402886-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF PITHD1, MLN, TPP1 POLB 3751/4885LMNA 2910/4885ALDH1A1 810/4885
US-20230219914-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF PITHD1, MLN, TPP1 POLB 3751/4885LMNA 2910/4885ALDH1A1 810/4885
US-11623920-B2 Process for preparing pitolisant hydrochloride and solid-state forms thereof PITHD1, MLN, TPP1 POLB 3751/4885LMNA 2910/4885ALDH1A1 810/4885
US-20200181038-A1 DECOMPOSITION OF ORGANIC PEROXIDES AND HYDROGEN PEROXIDE BY THE IRON THIOLATES AND RELATED COMPLEXES GPX4, LPO, CAT POLB 351/4885LMNA 4433/4885ALDH1A1 809/4885
US-11242296-B2 Decomposition of organic peroxides and hydrogen peroxide by the iron thiolates and related complexes GPX4, LPO, CAT POLB 351/4885LMNA 4433/4885ALDH1A1 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.